$PFE Company News You'd have to be a dope to buy
Post# of 88926
Posted On: 02/20/2014 10:42:17 AM
$PFE Company News
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
Australia regulator takes action against Pfizer 11:03 p.m. Feb. 12, 2014 - MarketWatch.com
Pfizer, GE, Boeing lead early Dow advancers 9:34 a.m. Feb. 11, 2014 - William L. Watts
Judge likely to throw the book at Martoma, experts say 4:00 p.m. Feb. 6, 2014 - blogs.marketwatch.com
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Stock market live blog: Indexes break 2-day losing streak; Kors, Yum climb 3:43 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow after an upgrade on promising cancer-drug tests 11:07 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow with 3% gain following upgrade 10:11 a.m. Feb. 4, 2014 - Russ Britt
Pfizer leads Dow with 3.3% gain following upgrade 10:03 a.m. Feb. 4, 2014 - Russ Britt
Pfizer advances 4.2% at the open, leads Dow 9:33 a.m. Feb. 4, 2014 - Victor Reklaitis
U.S. stocks see worst selloff in several months 4:41 p.m. Feb. 3, 2014 - Anora Mahmudova
Biggest drops since June for Dow industrials, S&P 500: stock market live blog recap 4:26 p.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer, Randgold gain in slumping stock market 3:52 p.m. Feb. 3, 2014 - Saumya Vaishampayan
Pfizer shares get a boost on positive results for breast-cancer treatment 10:37 a.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer breast-cancer study meets endpoint 8:37 a.m. Feb. 3, 2014 - MarketWatch.com
The inscrutable gold timers 10:26 a.m. Jan. 30, 2014 - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:01 p.m. Feb. 19, 2014 - TheStreet.com
Wall Street Winners: Were Analyst 2014 Picks Worth Their Salt? 8:53 a.m. Feb. 18, 2014 - Seeking Alpha
If Adam Smith Were Alive, He'd Be A Dividend Investor 6:51 a.m. Feb. 15, 2014 - Seeking Alpha
If Adam Smith Were Alive, He Would Be A Dividend Investor 6:51 a.m. Feb. 15, 2014 - Seeking Alpha
Dow Today: Pfizer (PFE) Leads The Day Higher, AT&T (T) Lags 10:00 a.m. Feb. 14, 2014 - TheStreet.com
AbbVie Deserves More Respect 6:30 a.m. Feb. 14, 2014 - TheStreet.com
Pfizer Needs a Healthy Dose of Investor Love 6:00 a.m. Feb. 14, 2014 - TheStreet.com
Pfizer's Finally a Buy 1:13 p.m. Feb. 13, 2014 - Barrons.com
10 Reasons To Buy Durect Right Now 10:45 a.m. Feb. 13, 2014 - Seeking Alpha
Australian regulator sues Pfizer over Lipitor sales tactics 9:58 a.m. Feb. 13, 2014 - Seeking Alpha
Pfizer Australia Faces Antitrust Probe 12:05 a.m. Feb. 13, 2014 - WSJ.com
Update on Bayer's Aleve - Analyst Blog 4:45 p.m. Feb. 12, 2014 - Zacks.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Feb. 12, 2014 - Zacks.com
FDA News: Aleve Is Not Safer Than Advil, Ibuprofen & Celebrex 5:50 a.m. Feb. 12, 2014 - InvestorPlace.com
FDA Panel Rejects Changing Painkiller Labels 5:32 p.m. Feb. 11, 2014 - WSJ.com
Marginal Earnings Beat at Zoetis in Q4, Guidance Weak - Analyst Blog 10:57 a.m. Feb. 11, 2014 - Zacks.com
Zoetis Q4 Beats Estimates, But Guidance Hammers Stock 10:32 a.m. Feb. 11, 2014 - Investors Business Daily
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Pfizer Inc Stock Buy Recommendation Reiterated (PFE) 9:00 a.m. Feb. 11, 2014 - TheStreet.com
Zoetis Swings to Fourth-Quarter Profit 7:58 a.m. Feb. 11, 2014 - WSJ.com
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference 10:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Northeast Shows Nearly $7 Billion in Reasons to Love the Life Science Industry's Capital Investments, an Industrial Info News Alert 6:15 a.m. Feb. 13, 2014 - Marketwire
Pfizer Statement on Today’s Joint Meeting of FDA Advisory Committees 2:03 p.m. Feb. 11, 2014 - BusinessWire - BZX
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
LiveWorld and Pfizer to Present a Series of Panels on Social Media Within Regulated Industries at Social Media Week 10:00 a.m. Feb. 4, 2014 - BusinessWire - BZX
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
TrendingWallStreet.com Initiates Trend Analysis on GFOX, CMCSA, SKTO, and PFE 12:22 a.m. Feb. 4, 2014 - ACCESSWIRE
Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
Australia regulator takes action against Pfizer 11:03 p.m. Feb. 12, 2014 - MarketWatch.com
Pfizer, GE, Boeing lead early Dow advancers 9:34 a.m. Feb. 11, 2014 - William L. Watts
Judge likely to throw the book at Martoma, experts say 4:00 p.m. Feb. 6, 2014 - blogs.marketwatch.com
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Stock market live blog: Indexes break 2-day losing streak; Kors, Yum climb 3:43 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow after an upgrade on promising cancer-drug tests 11:07 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow with 3% gain following upgrade 10:11 a.m. Feb. 4, 2014 - Russ Britt
Pfizer leads Dow with 3.3% gain following upgrade 10:03 a.m. Feb. 4, 2014 - Russ Britt
Pfizer advances 4.2% at the open, leads Dow 9:33 a.m. Feb. 4, 2014 - Victor Reklaitis
U.S. stocks see worst selloff in several months 4:41 p.m. Feb. 3, 2014 - Anora Mahmudova
Biggest drops since June for Dow industrials, S&P 500: stock market live blog recap 4:26 p.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer, Randgold gain in slumping stock market 3:52 p.m. Feb. 3, 2014 - Saumya Vaishampayan
Pfizer shares get a boost on positive results for breast-cancer treatment 10:37 a.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer breast-cancer study meets endpoint 8:37 a.m. Feb. 3, 2014 - MarketWatch.com
The inscrutable gold timers 10:26 a.m. Jan. 30, 2014 - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:01 p.m. Feb. 19, 2014 - TheStreet.com
Wall Street Winners: Were Analyst 2014 Picks Worth Their Salt? 8:53 a.m. Feb. 18, 2014 - Seeking Alpha
If Adam Smith Were Alive, He'd Be A Dividend Investor 6:51 a.m. Feb. 15, 2014 - Seeking Alpha
If Adam Smith Were Alive, He Would Be A Dividend Investor 6:51 a.m. Feb. 15, 2014 - Seeking Alpha
Dow Today: Pfizer (PFE) Leads The Day Higher, AT&T (T) Lags 10:00 a.m. Feb. 14, 2014 - TheStreet.com
AbbVie Deserves More Respect 6:30 a.m. Feb. 14, 2014 - TheStreet.com
Pfizer Needs a Healthy Dose of Investor Love 6:00 a.m. Feb. 14, 2014 - TheStreet.com
Pfizer's Finally a Buy 1:13 p.m. Feb. 13, 2014 - Barrons.com
10 Reasons To Buy Durect Right Now 10:45 a.m. Feb. 13, 2014 - Seeking Alpha
Australian regulator sues Pfizer over Lipitor sales tactics 9:58 a.m. Feb. 13, 2014 - Seeking Alpha
Pfizer Australia Faces Antitrust Probe 12:05 a.m. Feb. 13, 2014 - WSJ.com
Update on Bayer's Aleve - Analyst Blog 4:45 p.m. Feb. 12, 2014 - Zacks.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Feb. 12, 2014 - Zacks.com
FDA News: Aleve Is Not Safer Than Advil, Ibuprofen & Celebrex 5:50 a.m. Feb. 12, 2014 - InvestorPlace.com
FDA Panel Rejects Changing Painkiller Labels 5:32 p.m. Feb. 11, 2014 - WSJ.com
Marginal Earnings Beat at Zoetis in Q4, Guidance Weak - Analyst Blog 10:57 a.m. Feb. 11, 2014 - Zacks.com
Zoetis Q4 Beats Estimates, But Guidance Hammers Stock 10:32 a.m. Feb. 11, 2014 - Investors Business Daily
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Pfizer Inc Stock Buy Recommendation Reiterated (PFE) 9:00 a.m. Feb. 11, 2014 - TheStreet.com
Zoetis Swings to Fourth-Quarter Profit 7:58 a.m. Feb. 11, 2014 - WSJ.com
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference 10:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Northeast Shows Nearly $7 Billion in Reasons to Love the Life Science Industry's Capital Investments, an Industrial Info News Alert 6:15 a.m. Feb. 13, 2014 - Marketwire
Pfizer Statement on Today’s Joint Meeting of FDA Advisory Committees 2:03 p.m. Feb. 11, 2014 - BusinessWire - BZX
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
LiveWorld and Pfizer to Present a Series of Panels on Social Media Within Regulated Industries at Social Media Week 10:00 a.m. Feb. 4, 2014 - BusinessWire - BZX
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
TrendingWallStreet.com Initiates Trend Analysis on GFOX, CMCSA, SKTO, and PFE 12:22 a.m. Feb. 4, 2014 - ACCESSWIRE
Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼